Axa’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,500
| Closed | -$27.2K | – | 1174 |
|
|
2023
Q2 | $27.2K | Buy |
+10,500
| New | +$27.2K | ﹤0.01% | 1072 |
|
|
2023
Q1 | – | Sell |
-113,600
| Closed | -$570K | – | 1201 |
|
|
2022
Q4 | $570K | Sell |
113,600
-292,083
| -72% | -$1.47M | ﹤0.01% | 974 |
|
|
2022
Q3 | $5.31M | Buy |
405,683
+3,240
| +0.8% | +$42.4K | 0.02% | 565 |
|
|
2022
Q2 | $5.16M | Sell |
402,443
-7,825
| -2% | -$100K | 0.02% | 575 |
|
|
2022
Q1 | $6.26M | Buy |
410,268
+4
| +0% | +$61 | 0.02% | 586 |
|
|
2021
Q4 | $7.27M | Buy |
410,264
+4,897
| +1% | +$86.7K | 0.02% | 571 |
|
|
2021
Q3 | $8.52M | Buy |
405,367
+112,926
| +39% | +$2.37M | 0.02% | 544 |
|
|
2021
Q2 | $5.77M | Buy |
+292,441
| New | +$5.77M | 0.02% | 667 |
|